微泰医疗器械（杭州）股份有限公司（股票代码：02235）于2026年1月16日更新翌日披露报表，显示公司在香港联合交易所进行股份回购。公告日期为2026年1月16日，本次回购以H股普通股形式进行。
本次回购数量为20,100股，占回购前已发行股本约0.0121%。回购价格区间为每股7.75港元至7.80港元，合计使用资金约156,666港元。回购后，公司已发行股份总数为165,904,142股，库藏股数量增至3,271,700股。
根据公告，回购授权于2025年5月28日获得通过，可回购股份总数为16,668,364股。截至目前，公司累计回购719,500股，约占授权通过时已发行股本0.4317%。公司确认已遵守香港联交所上市规则及相关法律法规。公告由公司执行董事及联席公司秘书施永辉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.